Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15,967Revenue $M12,795Net Margin (%)5.7Z-Score2.1
Enterprise Value $M22,719EPS $3.3Operating Margin %14.2F-Score5
P/E(ttm))22.2Cash Flow Per Share $8.2Pre-tax Margin (%)10.2Higher ROA y-yN
Price/Book3.110-y EBITDA Growth Rate %15.5Quick Ratio1.6Cash flow > EarningsY
Price/Sales1.35-y EBITDA Growth Rate %16.0Current Ratio1.6Lower Leverage y-yY
Price/Cash Flow13.1y-y EBITDA Growth Rate %18.1ROA % (ttm)4.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)15.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M215ROI % (ttm)3.4Gross Margin Increase y-yN

Gurus Latest Trades with DVA

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVASteve Mandel 2014-12-31 Buy 1.3%$72.03 - $78.07
($75.35)
$ 74.3-1%New holding, 3940169 sh.3,940,169
DVAAndreas Halvorsen 2014-12-31 Add0.17%$72.03 - $78.07
($75.35)
$ 74.3-1%Add 12.2%4,466,740
DVAJoel Greenblatt 2014-12-31 Add0.16%$72.03 - $78.07
($75.35)
$ 74.3-1%Add 240.25%352,562
DVARay Dalio 2014-12-31 Add0.01%$72.03 - $78.03
($75.28)
$ 74.3-1%Add 88.59%50,026
DVAMario Gabelli 2014-12-31 Reduce-0.03%$72.03 - $78.03
($75.28)
$ 74.3-1%Reduce -63.03%42,763
DVAAndreas Halvorsen 2014-09-30 Add0.15%$71.01 - $74.94
($73.27)
$ 74.31%Add 14.1%3,981,170
DVAAndreas Halvorsen 2014-06-30 Add0.5%$67.12 - $72.95
($69.49)
$ 74.37%Add 82%3,489,084
DVAMario Gabelli 2014-06-30 Add0.03%$67.12 - $72.95
($69.49)
$ 74.37%Add 330.08%114,328
DVASteve Mandel 2014-06-30 Sold Out -1.1%$67.12 - $72.95
($69.49)
$ 74.37%Sold Out0
DVAJoel Greenblatt 2014-06-30 Reduce-0.11%$67.12 - $72.95
($69.49)
$ 74.37%Reduce -49.01%110,765
DVARay Dalio 2014-06-30 Reduce-0.02%$67.12 - $72.95
($69.49)
$ 74.37%Reduce -52.11%31,098
DVAAndreas Halvorsen 2014-03-31 Add0.1%$62.74 - $69.81
($66.3)
$ 74.312%Add 22.06%1,917,104
DVAMario Gabelli 2014-03-31 Buy 0.01%$62.74 - $69.81
($66.3)
$ 74.312%New holding, 26583 sh.26,583
DVASteve Mandel 2014-03-31 Reduce-1.31%$62.74 - $69.81
($66.3)
$ 74.312%Reduce -56.84%3,655,739
DVARay Dalio 2014-03-31 Reduce-0.01%$62.74 - $69.81
($66.3)
$ 74.312%Reduce -30.5%64,941
DVASteve Mandel 2013-12-31 Add0.59%$55.03 - $63.39
($58.62)
$ 74.327%Add 34.41%8,470,777
DVAAndreas Halvorsen 2013-12-31 Buy 0.46%$55.03 - $63.39
($58.62)
$ 74.327%New holding, 1570667 sh.1,570,667
DVAWarren Buffett 2013-12-31 Add0.3%$55.03 - $63.39
($58.62)
$ 74.327%Add 15.95%36,461,294
DVAJoel Greenblatt 2013-12-31 Add0.21%$55.03 - $63.39
($58.62)
$ 74.327%Add 171.1%221,775
DVARichard Perry 2013-12-31 Sold Out -0.36%$55.03 - $63.39
($58.62)
$ 74.327%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DVA Steve Mandel 2014-12-313,940,1691.831.3New Buy
DVA Joel Greenblatt 2014-12-31352,5620.160.22+240.25%
DVA Ray Dalio 2014-12-3150,0260.020.03+88.59%
DVA Andreas Halvorsen 2014-12-314,466,7402.081.6+12.2%
DVA Warren Buffett 2014-12-3138,565,57017.952.7+2.51%
DVA Mario Gabelli 2014-12-3142,7630.020.02-63.03%
Premium Most recent portfolio changes are included for Premium Members only!


DVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Margolis Robert JCo-Chairman of the Board 2015-02-19Sell21,000$73.121.71view
Margolis Robert JCo-Chairman of the Board 2015-01-30Sell31,400$75.48-1.47view
STAFFIERI MICHAEL DAVIDCOO, Kidney Care 2015-01-23Sell21,869$76.05-2.21view
Margolis Robert JCo-Chairman of the Board 2015-01-16Sell31,400$74.92-0.73view
Rivera Kim MChief Legal Officer 2015-01-08Sell1,111$75.1-0.97view
STAFFIERI MICHAEL DAVIDCOO, Kidney Care 2015-01-02Sell53,427$75.77-1.85view
Margolis Robert JCo-Chairman of the Board 2014-12-30Sell31,400$76.09-2.26view
Mildenberger LauraChief People Ofcr, Kidney Care 2014-12-19Sell1,446$75.5-1.5view
Margolis Robert JCo-Chairman of the Board 2014-12-18Sell31,400$74.67-0.4view
Margolis Robert JCo-Chairman of the Board 2014-12-03Sell31,400$75.8-1.89view

Press Releases about DVA :

    Quarterly/Annual Reports about DVA:

    News about DVA:

    Articles On GuruFocus.com
    Steve Mandel Buys Visa, DaVita Healthcare In Q4 Feb 19 2015 
    How Berkshire Hathaway's Todd Combs and Ted Weschler Performed Relative To The S&P 500 in 2014 Jan 13 2015 
    Weekly Insider Sells Highlight: ADP, KMX, SYK, DVA Jan 05 2015 
    Weekly Insider Sells Highlight: FB, DVA, DATA, MCK, TXN Nov 18 2014 
    DaVita HealthCare Partners is a Great Business With Solid Growth Potential Aug 30 2014 
    DaVita Seems to be a High-Growth Company Aug 20 2014 
    Mario Gabelli Reports his Top Increase of the Second Quarter Aug 07 2014 
    Warren Buffett's 3 High-Conviction Stocks Jun 13 2014 
    Thoughts on Ted Weschler's Largest Holding and Excellent Long-Term Results Mar 14 2014 
    Buffett's Investor Pick Ted Weschler Discusses DaVita Inc. Mar 03 2014 

    More From Other Websites
    DaVita HealthCare Partners to Work With Achievement First to Build Culture Between School and... Feb 25 2015
    DAVITA HEALTHCARE PARTNERS INC. Files SEC form 8-K, Regulation FD Disclosure Feb 24 2015
    DaVita Kidney Care Announces its First Chief Medical Officer for International Operations Feb 24 2015
    DaVita HealthCare Partners Celebrates 10 Years Among FORTUNE Magazine's World's Most Admired... Feb 19 2015
    DaVita Beats on Q4 Earnings, Down Y/Y; Retains '15 View - Analyst Blog Feb 13 2015
    DaVita HealthCare Partners Inc. (DVA): New Analyst Report from Zacks Equity Research - Zacks Equity... Feb 13 2015
    DaVita HealthCare Partners (DVA) Earnings Report: Q4 2014 Conference Call Transcript Feb 13 2015
    DaVita HealthCare Partners Inc Earnings Call scheduled for 5:00 pm ET today Feb 12 2015
    DAVITA HEALTHCARE PARTNERS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 12 2015
    DaVita HealthCare tops Street 4Q forecasts Feb 12 2015
    DaVita HealthCare tops Street 4Q forecasts Feb 12 2015
    DaVita HealthCare Partners Inc. 4th Quarter 2014 Results Feb 12 2015
    Q4 2014 DaVita HealthCare Partners Inc Earnings Release - After Market Close Feb 12 2015
    DaVita HealthCare Partners Ranked 38th Among 2015 Training Top 125 Feb 11 2015
    DaVita Healthcare (DVA): What's in Store for Q4 Earnings? - Analyst Blog Feb 10 2015
    DaVita Kidney Care Leads in Immunizations for 2014-2015 Season Feb 05 2015
    DaVita Kidney Care Leads in Immunizations for 2014-2015 Season Feb 05 2015
    Tandigm Health Signs Landmark Agreement with Holy Redeemer Health System and Innovative Wellness... Feb 04 2015
    Centura Health and DaVita HealthCare Partners Introduce FullWell Jan 30 2015
    Centura Health and DaVita HealthCare Partners Introduce FullWell Jan 30 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK